MEDICINES Australia (MA) yesterday announced the appointment of its director of Policy & Research, Elizabeth de Somer (pictured) as the organisation's interim ceo (PD breaking news), subsequent to Milton Catelin's recent resignation.
Medicines Australia chair Wes Cook said he was confident the interim ceo would provide continuity, stability and strong leadership for both MA and its stakeholders until a permanent appointment is made.
"Ms de Somer is highly respected both inside and outside the medicines industry due to ongoing contributions," Cook said.
He said as the current director of Policy & Research within the secretariat, de Somer has had a long and successful career within Medicines Australia, having worked within the organisation since 2007.
Cook also paid tribute to the outgoing Catelin for his "tremendous job working with the Board, the secretariat and members to continue building on strong and meaningful partnerships with our stakeholders".
Catelin is returing to the UK, with de Somer taking over next week.
The Medicines Australia Board Nominations Sub-Committee has appointed Brooker Consulting to run the recruitment process for a permanent CEO.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Mar 18
